Alpine Immune Sciences Inc buy BiotechBee
Start price
22.07.23
/
50%
€11.50
Target price
31.08.26
€15.00
Performance (%)
430.43%
End price
12.04.24
€61.00
Summary
This prediction ended on 12.04.24 with a price of €61.00. With a performance of 430.43% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionAlpine Immune Sciences is a clinical-stage biotechnology company focused on developing novel therapies that modulate the immune system to treat cancer, autoimmune, and inflammatory diseases. The company's proprietary platform technology, called "Variant Ig Domain" (vIgD), enables the design and development of unique protein therapeutics that can target specific immune cells and pathways. Alpine's lead product candidate, ALPN-202, is a dual ICOS/CD28 antagonist for the treatment of autoimmune and inflammatory diseases, and the company has several other product candidates in preclinical development. Alpine Immune Sciences is listed on the NASDAQ stock exchange under the ticker symbol "ALPN".
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Alpine Immune Sciences Inc | -0.820% | -0.820% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
According to BiotechBee what are the pros and cons of Alpine Immune Sciences Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Alpine Immune Sciences Inc diskutieren
Buy mit Kursziel 15,0